Atopic Dermatitis models / Pathology background / Clinical views

Imavita / Atopic Dermatitis

Atopic Dermatitis or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children. Symptomatic treatment of atopic dermatitis relies primarily on the use of topical formulations (corticosteroids and immunosuppressors). Physicians consider current oral treatments to have limited value in the treatment of atopic dermatitis; antihistamines are the primary class of oral agents used. Due to its chronic and relapsing nature, atopic dermatitis presents a global public health concern, with reported lifetime prevalence ranging between 10%-20% in children and 1%-3% in adults

Atopic Dermatitis (AD) Preclinical Models Overview

Oxazolone-induced AD preclinical model

  • Sensitization and repeated challenge with oxazolone / topically on back and ear (hapten induction)
  • Go to details on model

IL23-induced AD preclinical model

Itching preclinical model

Please inquire for more details on Atopic Dermatitis models